The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): a multicentre international randomised controlled trial
Open accessAbstract
Background Pregnant women with type 1 diabetes are a high-risk population who are recommended to strive for optimal glucose control, but neonatal outcomes attributed to maternal hyperglycaemia remain suboptimal. Our aim was to examine the effectiveness of continuous glucose monitoring (CGM) on maternal glucose control and obstetric and neonatal health outcomes. Methods In this multicentre, open-label, randomised controlled trial, we recruited women aged 18–40 years with type 1 diabetes for a minimum of 12 months who were receiving intensive insulin therapy. Participants were pregnant (≤13 weeks and 6 days' gestation) or planning pregnancy from 31 hospitals in Canada, England, Scotland, Spain, Italy, Ireland, and the USA. We ran two trials in parallel for pregnant participants and for participants planning pregnancy. In both trials, participants were randomly assigned to either CGM in addition to capillary glucose monitoring or capillary glucose monitoring alone. Randomisation was stratified by insulin delivery (pump or injections) and baseline glycated haemoglobin (HbA 1c ). The primary outcome was change in HbA 1c from randomisation to 34 weeks' gestation in pregnant women and to 24 weeks or conception in women planning pregnancy, and was assessed in all randomised participants with baseline assessments. Secondary outcomes included obstetric and neonatal health outcomes, assessed with all available data without imputation. This trial is registered with ClinicalTrials.gov, number NCT01788527. Findings Between March 25, 2013, and March 22, 2016, we randomly assigned 325 women (215 pregnant, 110 planning pregnancy) to capillary glucose monitoring with CGM (108 pregnant and 53 planning pregnancy) or without (107 pregnant and 57 planning pregnancy). We found a small difference in HbA 1c in pregnant women using CGM (mean difference −0·19%; 95% CI −0·34 to −0·03; p=0·0207). Pregnant CGM users spent more time in target (68% vs 61%; p=0·0034) and less time hyperglycaemic (27% vs 32%; p=0·0279) than did pregnant control participants, with comparable severe hypoglycaemia episodes (18 CGM and 21 control) and time spent hypoglycaemic (3% vs 4%; p=0·10). Neonatal health outcomes were significantly improved, with lower incidence of large for gestational age (odds ratio 0·51, 95% CI 0·28 to 0·90; p=0·0210), fewer neonatal intensive care admissions lasting more than 24 h (0·48; 0·26 to 0·86; p=0·0157), fewer incidences of neonatal hypoglycaemia (0·45; 0·22 to 0·89; p=0·0250), and 1-day shorter length of hospital stay (p=0·0091). We found no apparent benefit of CGM in women planning pregnancy. Adverse events occurred in 51 (48%) of CGM participants and 43 (40%) of control participants in the pregnancy trial, and in 12 (27%) of CGM participants and 21 (37%) of control participants in the planning pregnancy trial. Serious adverse events occurred in 13 (6%) participants in the pregnancy trial (eight [7%] CGM, five [5%] control) and in three (3%) participants in the planning pregnancy trial (two [4%] CGM and one [2%] control). The most common adverse events were skin reactions occurring in 49 (48%) of 103 CGM participants and eight (8%) of 104 control participants during pregnancy and in 23 (44%) of 52 CGM participants and five (9%) of 57 control participants in the planning pregnancy trial. The most common serious adverse events were gastrointestinal (nausea and vomiting in four participants during pregnancy and three participants planning pregnancy). Interpretation Use of CGM during pregnancy in patients with type 1 diabetes is associated with improved neonatal outcomes, which are likely to be attributed to reduced exposure to maternal hyperglycaemia. CGM should be offered to all pregnant women with type 1 diabetes using intensive insulin therapy. This study is the first to indicate potential for improvements in non-glycaemic health outcomes from CGM use. Funding Juvenile Diabetes Research Foundation, Canadian Clinical Trials Network, and National Institute for Health Research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“When used in addition to blood glucose monitoring, achieving traditional pre-and postprandial goals, real-time CGM can reduce the risk for large-for-gestational age infants and neonatal hypoglycemia in pregnancy complicated by type 1 diabetes.”
From 15. Management of Diabetes in Pregnancy: Standards of Care in Diabetes—2024 (2024) · cites this paper as [49]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Although there is no evidence regarding time in range for older and/or high-risk individuals, numerous studies have shown the elevated risk for hypoglycemia in these populations (54-59).”
From Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range (2019) · cites this paper as [59]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The increased risk of severe hypoglycemia is compounded by cognitive and physical impairments and other co-morbidities (56; 59).”
From Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range (2019) · cites this paper as [59]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“It demonstrated the value of real-time CGM in pregnancy complicated by type 1 diabetes by showing a mild improvement in A1C and a significant improvement in the maternal glucose time in range (TIR), without an increase in hypoglycemia, and reductions in large-for-gestational-age births, length of infant hospital stays, and severe neonatal hypoglycemia (49).”
From 15. Management of Diabetes in Pregnancy: Standards of Care in Diabetes—2024 (2024) · cites this paper as [49]
The cited source says what the claim attributes to it.
In the citing paper
“One RCT of rt-CGM use during pregnancy in women with type 1 diabetes showed a modest but statistically significant reduction of HbA 1c in women randomized to rt-CGM compared with those randomized to continuing to use blood glucose meters, with no differences in severe hypoglycemia.”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [184]
5 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
WARE, J. E., KOSINSKI, M., & KELLER, S. D. (1996) · Medical Care · doi:10.1097/00005650-199603000-00003 · Cited by 17,392
mice: Multivariate Imputation by Chained Equations in R
Buuren, S. V., & Groothuis-Oudshoorn, K. (2011) · Journal of Statistical Software · doi:10.18637/jss.v045.i03 · Cited by 13,870
Weight Gain During Pregnancy: Reexamining the Guidelines
Rasmussen, K. M., & Yaktine, A. L. (2009) · Cited by 4,473
Continuous glucose monitoring and intensive treatment of type 1 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0805017 · Cited by 1,559
Beck, R. W., Riddlesworth, T., Ruedy, K., Ahmann, A., Bergenstal, R., Haller, S., Kollman, C., Kruger, D., McGill, J. B., Polonsky, W., et al. (2017) · JAMA · doi:10.1001/jama.2016.19975 · Cited by 1,185
Self-citationBolinder, J., Antuna, R., Geelhoed-Duijvestijn, P., Kröger, J., & Weitgasser, R. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31535-5 · Cited by 893
Evers, I. M., de Valk, H. W., & Visser, G. H. A. (2004) · BMJ · doi:10.1136/bmj.38043.583160.ee · Cited by 775
Lind, M., Polonsky, W., Hirsch, I. B., Heise, T., Bolinder, J., Dahlqvist, S., Schwarz, E., Ólafsdóttir, A. F., Frid, A., Wedel, H., et al. (2017) · JAMA · doi:10.1001/jama.2016.19976 · Cited by 705
Macintosh, M. C. M., Fleming, K. M., Bailey, J. A., Doyle, P., Modder, J., Acolet, D., Golightly, S., & Miller, A. (2006) · BMJ · doi:10.1136/bmj.38856.692986.ae · Cited by 673
The problem areas in diabetes scale: an evaluation of its clinical utility
Welch, G. W., Jacobson, A. M., & Polonsky, W. H. (1997) · Diabetes Care · doi:10.2337/diacare.20.5.760 · Cited by 664
Research works printed but not linked: 1
- van Buuren, 2011, Multivariate imputation by chained equations in R, J Stat Softw, 45, 1
Cited by
Battelino, T., Danne, T., Bergenstal, R. M., Amiel, S. A., Beck, R., Biester, T., Bosi, E., Buckingham, B. A., Cefalu, W. T., Close, K. L., et al. (2019) · Diabetes Care · doi:10.2337/dci19-0028 · Cited by 4,237
Self-citationThe importance of nutrition in pregnancy and lactation: lifelong consequences
Marshall, N. E., Abrams, B., Barbour, L. A., Catalano, P., Christian, P., Friedman, J. E., Hay, W. W., Hernandez, T. L., Krebs, N. F., Oken, E., et al. (2022) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2021.12.035 · Cited by 709
Holt, R. I. G., DeVries, J. H., Hess-Fischl, A., Hirsch, I. B., Kirkman, M. S., Klupa, T., Ludwig, B., Nørgaard, K., Pettus, J., Renard, E., et al. (2021) · Diabetes Care · doi:10.2337/dci21-0043 · Cited by 699
Self-citationGlycaemic variability in diabetes: clinical and therapeutic implications
Ceriello, A., Monnier, L., & Owens, D. (2019) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(18)30136-0 · Cited by 588
Blonde, L., Umpierrez, G. E., Reddy, S. S., McGill, J. B., Berga, S. L., Bush, M., Chandrasekaran, S., DeFronzo, R. A., Einhorn, D., Galindo, R. J., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.08.002 · Cited by 507
Metadata
- Authors
- Feig, D. S., Donovan, L. E., Corcoy, R., Murphy, K. E., Amiel, S. A., Hunt, K. F., Asztalos, E., Barrett, J. F. R., Sanchez, J. J., de Leiva, A., Hod, M., Jovanovic, L., Keely, E., McManus, R., Hutton, E. K., Meek, C. L., Stewart, Z. A., Wysocki, T., O'Brien, R., Ruedy, K., Kollman, C., Tomlinson, G., Murphy, H. R., Grisoni, J., Byrne, C., Davenport, K., Neoh, S., Gougeon, C., Oldford, C., Young, C., Green, L., Rossi, B., Rogers, H., Cleave, B., Strom, M., Adelantado, J. M., Isabel Chico, A., Tundidor, D., Malcolm, J., Henry, K., Morris, D., Rayman, G., Fowler, D., Mitchell, S., Rosier, J., Temple, R., Turner, J., Canciani, G., Hewapathirana, N., Piper, L., Kudirka, A., Watson, M., Bonomo, M., Pintaudi, B., Bertuzzi, F., Daniela, G., Mion, E., Lowe, J., Halperin, I., Rogowsky, A., Adib, S., Lindsay, R., Carty, D., Crawford, I., Mackenzie, F., McSorley, T., Booth, J., McInnes, N., Smith, A., Stanton, I., Tazzeo, T., Weisnagel, J., Mansell, P., Jones, N., Babington, G., Spick, D., MacDougall, M., Chilton, S., Cutts, T., Perkins, M., Scott, E., Endersby, D., Dover, A., Dougherty, F., Johnston, S., Heller, S., Novodorsky, P., Hudson, S., Nisbet, C., Ransom, T., Coolen, J., Baxendale, D., Holt, R., Forbes, J., Martin, N., Walbridge, F., Dunne, F., Conway, S., Egan, A., Kirwin, C., Maresh, M., Kearney, G., Morris, J., Quinn, S., Bilous, R., Mukhtar, R., Godbout, A., Daigle, S., Lubina, A., Jackson, M., Paul, E., Taylor, J., Houlden, R., Breen, A., Banerjee, A., Brackenridge, A., Briley, A., Reid, A., Singh, C., Newstead-Angel, J., Baxter, J., Philip, S., Chlost, M., Murray, L., Castorino, K., Frase, D., Lou, O., & Pragnell, M.
- Affiliations
- University of Toronto (CA)
- University of Calgary (CA)
- Hospital de Sant Pau (ES)
- King's College London (GB)
- Sunnybrook Hospital (CA)
- Rabin Medical Center (IL)
- University of Ottawa (CA)
- Western University (CA)
- McMaster University (CA)
- Cambridge University Hospitals NHS Foundation Trust (GB)
- Nemours Children's Health System (US)
- Jaeb Center for Health Research (US)
- University Health Network (CA)
- University of East Anglia (GB)
- Corresponding author
- Feig, Denice S
- ORCID
- Feig, Denice S
- Donovan, Lois E
- Corcoy, Rosa
- Murphy, Kellie E
- Amiel, Stephanie A
- Hunt, Katharine F
- Asztalos, Elizabeth
- Barrett, Jon F R
- Sanchez, J Johanna
- Hutton, Eileen K
- Meek, Claire L
- Wysocki, Tim
- Kollman, Craig
- Tomlinson, George
- Murphy, Helen R
- Neoh, Sandra
- Rossi, Benedetta
- Rogers, Helen
- Tundidor, Diana
- Malcolm, Janine
- Rayman, Gerry
- Watson, Margaret
- Pintaudi, Basilio
- Bertuzzi, Federico
- Lowe, Julia
- Halperin, Ilana
- Lindsay, Robert
- Carty, David
- McInnes, Natalia
- Jones, Nia
- Scott, Eleanor
- Johnston, Susan
- Heller, Simon
- Hudson, Sue
- Holt, Richard
- Dunne, Fidelma
- Egan, Aoife
- Maresh, Michael
- Morris, Juliet
- Mukhtar, Rasha
- Houlden, Robyn
- Banerjee, Anita
- Brackenridge, Anna
- Briley, Annette
- Singh, Claire
- Philip, Sam
- Castorino, Kristin
- Pragnell, Marlon
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 2017-11
- Volume
- 390
- Issue
- 10110
- Pages
- 2347-2359
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- PMC
- PMC5713979
- OpenAlex
- W2755734682
- Semantic Scholar
- 928c8a4b15e234a70f185365778eef09887b3949
- Cited by
- 803
- References
- 34
- Citations by year
- 2026: 87 · 2025: 110 · 2024: 119 · 2023: 102 · 2022: 80 · 2021: 93 · 2020: 71 · 2019: 68 · 2018: 62 · 2017: 8
- FWCI
- 67.29
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by/4.0/ (vor)
- Locations
- The Lancet (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (acceptedVersion)
- UEA Digital Repository (University of East Anglia) (acceptedVersion)
- Figshare (submittedVersion, cc-by)
- Research Portal (King's College London) (submittedVersion, cc-by)
- Leicester Research Archive (University of Leicester) (submittedVersion, cc-by-nc-nd)
- Apollo (University of Cambridge) (submittedVersion, cc-by)
- Apollo (cc-by)
- Funders
- Sunnybrook Research Institute
- National Institute for Health and Care Research (ACF-2016-14-009, CDF-2013-06-035, 2013-06-035)
- University of Cambridge
- Cambridge University Hospitals
- Tommy's
- FedDev Ontario
- Breakthrough T1D Canada (17-2012-383)
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
- Keywords
- continuous glucose monitoring, type 1 diabetes in pregnancy, HbA1c, maternal glucose control, intensive insulin therapy, neonatal outcomes, obstetric outcomes, preconception care, time in target glucose range, hypoglycemia, maternal hyperglycemia
- MeSH terms
- Adolescent, Adult, Blood Glucose, Diabetes Mellitus, Type 1, Female, Humans, Insulin, Monitoring, Physiologic, Pregnancy, Pregnancy Outcome, Severity of Illness Index, Observer Variation, Odds Ratio, Risk Assessment, Internationality, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): a multicentre international randomised controlled trial. https://app.cochat.ai/papers/10.1016/s0140-6736(17)32400-5
- The paper
- Feig, D. S., Donovan, L. E., Corcoy, R., Murphy, K. E., Amiel, S. A., Hunt, K. F., Asztalos, E., Barrett, J. F. R., Sanchez, J. J., de Leiva, A., Hod, M., Jovanovic, L., Keely, E., McManus, R., Hutton, E. K., Meek, C. L., Stewart, Z. A., Wysocki, T., O'Brien, R., . . . Pragnell, M. (2017). Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): a multicentre international randomised controlled trial. The Lancet. https://doi.org/10.1016/s0140-6736(17)32400-5
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.